Clinical Trial Update: Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients [Phase 4]

View source ↗

Summary

Open-label Phase 4 study assessing long-term safety of Caduet in Japanese patients completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypercholesterolemia
• Hypertension

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2012-12-03